Moderate-to-good acceptability of smartwatch monitoring in head and neck cancer survivors: findings from the MOVE-1 feasibility study
Karl Vietinghoff, Susanne Fischer, Sabina Ulbricht, Daniel Strueder, Theresa Momper, Christian Junghanss, Sabine Felser · 2026
Read Moderate-to-good acceptability of smartwatch monitoring in head and neck cancer survivors: findings from the MOVE-1 feasibility study by Karl Vietinghoff, Susanne Fischer, Sabina Ulbricht, Daniel Strueder, Theresa Momper, Christian Junghanss, Sabine Felser (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13271956.txt.
Description
Karl Vietinghoff and coauthors test in 2026 whether smartwatch tracking is workable for people recovering from head and neck cancer. Activity supports recovery, yet survivors often move less than advised because of lasting treatment effects. A watch that records steps and heart rate could give steady feedback.
In the MOVE-1 study, survivors wore a smartwatch around the clock for seven days. Half of those approached agreed to join, and the team measured how completely heart rate data were captured. Participants also rated how often they checked the display and how usable the device felt. Acceptability landed in the moderate to good range.
Catalog record
| CREATOR | Karl Vietinghoff, Susanne Fischer, Sabina Ulbricht, Daniel Strueder, Theresa Momper, Christian Junghanss, Sabine Felser |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |